Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-26T19:10:41.052Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of rheumatic carditis with intravenous gammaglobulin: is there a beneficial effect?

Published online by Cambridge University Press:  15 August 2006

Karim A. Diab ,
Majd Ariss Timani  and
Fadi F. Bitar
Karim A. Diab
Affiliation:
Department of Pediatrics, American University of Beirut Medical Center, Beirut, Lebanon
Majd Ariss Timani
Affiliation:
Department of Pediatrics, American University of Beirut Medical Center, Beirut, Lebanon
Fadi F. Bitar
Affiliation:
Department of Pediatrics, American University of Beirut Medical Center, Beirut, Lebanon
Get access Rights & Permissions [Opens in a new window]

Abstract

Rheumatic carditis is a major manifestation of acute rheumatic fever. Conventional therapy includes the use of salicylates and steroids. To date, however, such therapy has not been proven to have a clear benefit in reducing valvar heart disease. We report the use of high-dose intravenous immunoglobulin in two chidlren with acute rheumatic carditis in whom we have been able to document the beneficial effect.

Keywords

Intravenous immunoglobulincarditisacute rheumatic fever
Type
Brief Report
Information
Cardiology in the Young , Volume 11 , Issue 5 , September 2001 , pp. 565 - 567
Copyright
2001 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)